Funding

Sahir Jaggi Co-Founded Forus Raises $150M in Series C Financing Round

Sep 9, 2026 | By Devin Jacobs

SUMMARY

Forus raised $150M in Series C funding.
The funding will support expansion and AI development.
Forus helps improve access to medicines.

Forus, a NYC-based AI network accelerating medicine, has raised $150 million in a Series C financing round led by Bain Capital Ventures at a $3 billion valuation.

The round also saw participation from existing investors Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures, and SV Angel.

The company will use the capital to expand across medical specialties and care settings, enhance its AI agents, and grow its team.

Funding Snapshot

Metric	Details
Fundraise Amount	$150 million
Funding Round	Series C
Valuation	$3 billion
Lead Investor	Bain Capital Ventures
Company	Forus
Sector	AI & Healthcare
Headquarters	New York City, USA

RECOMMENDED FOR YOU

Funding

AquaPoro Raises $5M in Seed Funding Led by Breakout Ventures

Devin Jacobs

Jun 25, 2026

Startup News

Arsenal Capital Partners Adds Max Schechter as Head of Industrial Growth Business Development

Devin Jacobs

Jun 20, 2026

Funding

KilgourMD Raises Series A Funding Led by Prelude Growth Partners

Devin Jacobs

Mar 27, 2026

About Forus

Founded by Sahir Jaggi, Forus is building an AI network connecting doctors, pharmacies, payers, and biopharma companies to improve access to medicines. Its AI agents work within provider workflows to manage processes between a clinical decision and a patient starting treatment.

Core offerings include:

AI-powered prescription agents
Insurance navigation
Financial assistance support
Pharmacy and supply-chain coordination

Core Technologies / Products / Services

Capability/Product	Application/Use Case
AI prescription agents	Managing the treatment-start process
Insurance navigation	Helping patients navigate coverage
Financial assistance	Supporting access to treatment
Healthcare network	Connecting providers, pharmacies, payers and biopharma

Leadership Comments

"We are putting the Forus platform in every doctor’s office in the country, so every disease is treated with the best medicine science can offer,” said Sahir Jaggi, CEO and founder of Forus. “Medicine is advancing faster than at any point in history, increasing the urgency to make sure those advances reach the people they're meant for.

"There were times a patient would come back after two or three months and tell me, 'I haven't even started the medication yet,'" said Dr. Brinda Dixit, rheumatologist at Virginia Rheumatology Clinic in Chesapeake, Virginia. "With Forus, approvals for these medications come back in less than two days, and patients start treatment within a week or two.